What is this ingredient? Folate is a water‑soluble B vitamin that participates in one‑carbon metabolism, a network of reactions needed for DNA synthesis and repair, red blood cell formation, and methylation processes throughout the body. In its supplemental form (often as folic acid or other folate derivatives), it helps convert homocysteine to methionine, supporting normal homocysteine levels and balanced methylation [1,2]. Inadequate folate intake can lead to megaloblastic anemia and, over time, may contribute to elevated homocysteine, which is linked to vascular dysfunction in observational studies [1].
Randomized trials and meta‑analyses consistently show that folic acid supplementation lowers blood homocysteine in a clear dose‑dependent fashion, with typical reductions of about 20–25% at commonly used doses [1,2,3]. These biochemical effects are most pronounced in people who start with higher homocysteine and lower folate status. In specific high‑risk groups, such as some patients with kidney disease, folic acid–based homocysteine‑lowering regimens have shown modest cardiovascular benefits, although this is not universal across all populations [5].
Why include it in this formula? The Fmlave NMN30000 Complex combines NMN, ergothioneine, spermidine, SOD, vitamin B12, and folate, pointing to a core focus on cellular energy metabolism, redox balance, and healthy aging. Within this design, folate forms a central "methylation and homocysteine" pillar. Working together with vitamin B12, it supports one‑carbon metabolism, DNA synthesis, and normal red blood cell production, providing foundational support for tissues that rely on rapid renewal [1,2].
Because NMN, spermidine, ergothioneine, and SOD target pathways related to mitochondrial function, autophagy, and oxidative stress, maintaining adequate folate ensures that basic genomic and vascular processes are also supported. Its homocysteine‑lowering effect complements the formula’s broader aim of supporting vascular and cellular health over time, creating a bridge between advanced longevity‑oriented actives and essential B‑vitamin biochemistry [1–3,5].
References
- [1] Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials
- [2] Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials
- [5] Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: a meta-analysis of randomized controlled trials